Deutsche Bank’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Deutsche Bank’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-503	Closed	-$41K	–	4365
2022 Q1	$41K	Sell	503 -53	-10%	-$6.55K	﹤0.01%	3899
2021 Q4	$114K	Buy	556 +181	+48%	+$45.2K	﹤0.01%	3649
2021 Q3	$121K	Buy	375 +235	+168%	+$68.6K	﹤0.01%	3821
2021 Q2	$36K	Buy	+140	New	+$42.7K	﹤0.01%	4357

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Deutsche Bank's VINC Position: Q2 2022 in Review

Deutsche Bank sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2022, closing a stake of 503 shares — an estimated $41K sold.

Deutsche Bank first reported a position in VINC in Q2 2021 and held it in 4 quarters. The position peaked at $121K in Q3 2021. 51 funds tracked by Wall St. Rank hold VINC as of Q2 2022.

Deutsche Bank reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 503 Vincerx Pharma, Inc. Common Stock shares in Q2 2022, an estimated $41K.
Deutsche Bank first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Deutsche Bank's Vincerx Pharma, Inc. Common Stock position peaked at $121K in Q3 2021.
51 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.